Published December 15, 2022 | Version v1
Journal article Open

Structural insights into p300 regulation and acetylation-dependent genome organisation

Description

Histone modifications are deposited by chromatin modifying enzymes and read out by proteins that recognize the modified state. BRD4-NUT is an oncogenic fusion protein of the acetyl lysine reader BRD4 that binds to the acetylase p300 and enables formation of long-range intra- and interchromosomal interactions. We here examine how acetylation reading and writing enable formation of such interactions. We show that NUT contains an acidic transcriptional activation domain that binds to the TAZ2 domain of p300. We use NMR to investigate the structure of the complex and found that the TAZ2 domain has an autoinhibitory role for p300. NUT-TAZ2 interaction or mutations found in cancer that interfere with autoinhibition by TAZ2 allosterically activate p300. p300 activation results in a self-organizing, acetylation-dependent feed-forward reaction that enables long-range interactions by bromodomain multivalent acetyl-lysine binding. We discuss the implications for chromatin organisation, gene regulation and dysregulation in disease.

Data availability

All data and materials generated during this investigation are available upon reasonable request to the corresponding author. Chemical shifts for NUT are available from the BMRB under accession ID 51611. The mass spectrometry proteomics data have been deposited to the ProteomeXchange Consortium via the PRIDE partner repository with the dataset identifier PXD038798. Source data are provided with this paper.

Files

Structural-insights-into-p300-regulation-and-acetylation-dependent-genome-organisation.pdf

Files (107.2 MB)

Name Size Download all
Supplementary information
md5:7a0edcf3109ac19899b90bb0be8c4992
5.8 MB Preview Download
Peer review file
md5:4a370a0924aa5ffca1c976f7d83eaa1b
3.5 MB Preview Download
Description of additional supplementary file
md5:d778bad9f5e267a7c5911aa4e6247627
86.8 kB Preview Download
Reporting summary
md5:7620c8fe65a4d1edbd3eec2a12380065
287.3 kB Preview Download
Source data
md5:54b101ed63ef0191f9d4aa75bb39a521
18.5 MB Download
Article
md5:010a17749c35aeee0f524e162a786f0f
8.8 MB Preview Download
Supplementary data files
md5:1353c5065060f82bfe3e33d45a3c307f
68.2 kB Preview Download
Supplementary movie files
md5:cf3a980698f40de6c2c23372d706b72c
70.2 MB Preview Download

Additional details

Identifiers

DOI
10.1038/s41467-022-35375-2
Other
oai:uchicago.tind.io:5344

Funding

ANR
Episperm4 programme
Plan Cancer Pitcher
MSD
Avenir ERICAN programmes
French Alliance for Life Sciences and Health (AVIESAN)
MIC programme
Université Grenoble Alpes
ANR-15-IDEX-02 SYMER
Université Grenoble Alpes
LIFE programmes
Fondation ARC programme
RF20190208471
BBSRC
BB/S019510/1
BBSRC
BB/R016275/1
Worldwide Cancer Research
16-0280
Wellcome Trust
221881/Z/20/Z
Instruct-ERIC
18571
Medical Research Council
MR/W001667/1

UChicago Information

Division(s)
Biological Sciences Division
Department(s)
Ben May Department for Cancer Research